A "rough" journey to the sarcoplasmic reticulum-implications of altered calsequestrin trafficking for cardiac arrhythmia

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 4, 2010, Pages 554-555

  Knollmann, Bjorn C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALSEQUESTRIN; JUNCTIN; RYANODINE RECEPTOR 2; TRIADIN; UNCLASSIFIED DRUG;

CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL TRANSPORT; EDITORIAL; ENDOPLASMIC RETICULUM; GENE TRANSFER; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN TRANSPORT; RISK FACTOR; SARCOPLASMIC RETICULUM;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALSEQUESTRIN; ENDOPLASMIC RETICULUM, ROUGH; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; RATS; SARCOPLASMIC RETICULUM;

EID: 77956171200     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.06.011     Document Type: Editorial

References (22)

1. MacLennan D.H., Wong P.T. Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci U.S.A. 1971 Jun, 68(6):1231-1235.
2. Knollmann B.C. New roles of calsequestrin and triadin in cardiac muscle. J Physiol 2009 Jul 1, 587(Pt 13):3081-3087.
3. Lahooti H., Parmar K.R., Wall J.R. Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?. Clin Ophthalmol 2010, 4:417-425.
4. Park H., Wu S., Dunker A.K., Kang C. Polymerization of calsequestrin. Implications for Ca2+ regulation. J Biol Chem 2003 May 2, 278(18):16176-16182.
5. Milstein M.L., Houle T.D., Cala S.E. Calsequestrin isoforms localize to different ER subcompartments: evidence for polymer and heteropolymer-dependent localization. Exp Cell Res 2009 Feb 1, 315(3):523-534.
6. Zhang L., Kelley J., Schmeisser G., Kobayashi Y.M., Jones L.R. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997 Sep 12, 272(37):23389-23397.
7. Scriven D.R., Dan P., Moore E.D. Distribution of proteins implicated in excitation-contraction coupling in rat ventricular myocytes. Biophys J 2000 Nov, 79(5):2682-2691.
8. Jorgensen A.O., Shen A.C., Campbell K.P. Ultrastructural localization of calsequestrin in adult rat atrial and ventricular muscle cells. J Cell Biol 1985 Jul, 101(1):257-268.
9. Chopra N., Yang T., Asghari P., Moore E.D., Huke S., Akin B., et al. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci U.S.A. 2009 May 5, 106(18):7636-7641.
10. Knollmann B.C., Chopra N., Hlaing T., Akin B., Yang T., Ettensohn K., et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006 Sep, 116(9):2510-2520.
11. Ikemoto N., Ronjat M., Meszaros L.G., Koshita M. Postulated role of calsequestrin in the regulation of calcium release from sarcoplasmic reticulum. Biochemistry 1989 Aug 8, 28(16):6764-6771.
12. Gyorke I., Hester N., Jones L.R., Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004 Apr, 86(4):2121-2128.
13. Jiang D., Chen W., Wang R., Zhang L., Chen S.R. Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death. Proc Natl Acad Sci U.S.A. 2007 Nov 13, 104(46):18309-18314.
14. Viatchenko-Karpinski S., Terentyev D., Gyorke I., Terentyeva R., Volpe P., Priori S.G., et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 2004 Mar 5, 94(4):471-477.
15. Terentyev D., Nori A., Santoro M., Viatchenko-Karpinski S., Kubalova Z., Gyorke I. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 2006 Apr 6.
16. Song L., Alcalai R., Arad M., Wolf C.M., Toka O., Conner D.A., et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2007 Jul, 117(7):1814-1823.
17. Rizzi N., Liu N., Napolitano C., Nori A., Turcato F., Colombi B., et al. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ Res 2008 Aug 1, 103(3):298-306.
18. Houle T.D., Ram M.L., Cala S.E. Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium. Cardiovasc Res 2004 Nov 1, 64(2):227-233.
19. Kalyanasundaram A., Bal N.C., Franzini-Armstrong C., Knollmann B.C., Periasamy M. The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering. J Biol Chem 2010 Jan 29, 285(5):3076-3083.
20. Bal N.C., Sharon A., Gupta S.C., Jena N., Shaikh S., Gyorke S., et al. The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization. J Biol Chem 2010 May 28, 285(22):17188-17196.
21. Kiarash A., Kelly C.E., Phinney B.S., Valdivia H.H., Abrams J., Cala S.E. Defective glycosylation of calsequestrin in heart failure. Cardiovasc Res 2004 Aug 1, 63(2):264-272.
22. Chopra N., Kannankeril P.J., Yang T., Hlaing T., Holinstat I., Ettensohn K., et al. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice. Circ Res 2007 Sep 14, 101(6):617-626.